Evidence map›Paper›PMID 34848685›Full record

ArticleNature communications2021

A DAP5/eIF3d alternate mRNA translation mechanism promotes differentiation and immune suppression by human regulatory T cells.

Viviana Volta, Sandra Pérez-Baos, Columba de la Parra, Olga Katsara, Amanda Ernlund, Sophie Dornbaum, Robert J Schneider

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. CIITA/PRMT5 promote CD4BMC medicine · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Dual relevance ofFrontiers in oncology · 2026
    Article
  7. Review
  8. Purification and characterization of recombinant human translation initiation factor eIF3.Protein science : a publication of the Protein Society · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Photoactivatable mRNA 5' Cap Analogs for RNA-Protein Crosslinking.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Trinucleotide mRNA Cap AnalogueJournal of the American Chemical Society · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Viviana Volta *Synthis LLC, 430 East 29th Street, Launch Labs, Alexandria Center for Life Sciences, New York, NY, 10016, USA.ORCID http://orcid.org/0000-0001-9999-3732
Sandra Pérez-Baos *Department of Microbiology, NYU Grossman School of Medicine, New York, NY, 10016, USA.ORCID http://orcid.org/0000-0002-3952-0148
Columba de la ParraDepartment of Chemistry, Herbert H. Lehman College, City University of New York, The Graduate Center, Biochemistry Ph.D. Program, City University of New York, New York, NY, 10016, USA.
Olga KatsaraDepartment of Microbiology, NYU Grossman School of Medicine, New York, NY, 10016, USA.
Amanda ErnlundJohns Hopkins Applied Physics Lab, 11000 Johns Hopkins Road, Laurel, MD, 20723, USA.
Sophie DornbaumDepartment of Microbiology, NYU Grossman School of Medicine, New York, NY, 10016, USA.
Robert J SchneiderDepartment of Microbiology, NYU Grossman School of Medicine, New York, NY, 10016, USA. robert.schneider@nyumc.org.ORCID http://orcid.org/0000-0001-5807-5564
New York University · USJohns Hopkins University Applied Physics Laboratory · USLaunchpad Central (United States) · USNYU Langone’s Laura and Isaac Perlmutter Cancer CenterThe Graduate Center, CUNY · US

Funding

Institutional Clinical and Translational Science AwardUL1TR000038 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2012 to 2014
$16.8M
TRAINING PROGRAM IN MOLECULAR ONCOLOGY &IMMUNOLOGYT32CA009161 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARROLL, WILLIAM L., LEVY, DAVID E · 1985 to 2020
$13.3M
Translational Regulation of T Regulatory CellsR01AI137067 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Robert Jay Schneider · 2018 to 2026
$5.2M
NCATS NIH HHS UL1 TR000038NCI NIH HHS T32 CA009161NIAID NIH HHS R01 AI137067
6 · The paper itself

Abstract

Regulatory T cells (Treg cells) inhibit effector T cells and maintain immune system homeostasis. Treg cell maturation in peripheral sites requires inhibition of protein kinase mTORC1 and TGF-beta-1 (TGF-beta). While Treg cell maturation requires protein synthesis, mTORC1 inhibition downregulates it, leaving unanswered how Treg cells achieve essential mRNA translation for development and immune suppression activity. Using human CD4

Indexed as

Cell DifferentiationImmunosuppression TherapyProtein BiosynthesisDown-RegulationEukaryotic Initiation Factor-3Eukaryotic Initiation Factor-4GGene Expression RegulationHEK293 CellsHomeostasisHumansLymphocyte ActivationMechanistic Target of Rapamycin Complex 1RNA, MessengerT-Lymphocytes, RegulatoryTransforming Growth Factor beta1EIF3D protein, humanEIF4G2 protein, humanEukaryotic Initiation Factor-3Eukaryotic Initiation Factor-4GMechanistic Target of Rapamycin Complex 1RNA, MessengerTGFB1 protein, humanTransforming Growth Factor beta1

Identifiers

PMID34848685
PMCPMC8632918
OpenAlexW3217049957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.